PROCTER & GAMBLE HEALTH | ZENITH HEALTH | PROCTER & GAMBLE HEALTH/ ZENITH HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 99.1 | 34.9% | View Chart |
P/BV | x | 10.6 | 3.4 | 306.8% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH ZENITH HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ZENITH HEALTH Mar-23 |
PROCTER & GAMBLE HEALTH/ ZENITH HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 8 | 69,412.7% | |
Low | Rs | 3,883 | 4 | 105,803.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 2.4 | 30,320.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0 | 952,403.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 0.1 | 232,917.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 1.3 | 33,262.1% | |
Shares outstanding (eoy) | m | 16.60 | 53.74 | 30.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.3 | 267.6% | |
Avg P/E ratio | x | 33.5 | 394.0 | 8.5% | |
P/CF ratio (eoy) | x | 29.8 | 85.6 | 34.8% | |
Price / Book Value ratio | x | 10.3 | 4.2 | 243.9% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 306 | 25,059.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 13 | 16,094.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 131 | 9,365.7% | |
Other income | Rs m | 184 | 4 | 4,891.0% | |
Total revenues | Rs m | 12,480 | 135 | 9,241.1% | |
Gross profit | Rs m | 3,247 | 0 | 1,082,266.7% | |
Depreciation | Rs m | 281 | 3 | 10,035.7% | |
Interest | Rs m | 8 | 0 | 11,000.0% | |
Profit before tax | Rs m | 3,142 | 1 | 266,271.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | 211,825.0% | |
Profit after tax | Rs m | 2,295 | 1 | 294,192.3% | |
Gross profit margin | % | 26.4 | 0.2 | 11,672.4% | |
Effective tax rate | % | 27.0 | 34.2 | 79.0% | |
Net profit margin | % | 18.7 | 0.6 | 3,149.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 71 | 16,409.1% | |
Current liabilities | Rs m | 6,791 | 20 | 33,684.5% | |
Net working cap to sales | % | 40.0 | 39.0 | 102.6% | |
Current ratio | x | 1.7 | 3.5 | 48.7% | |
Inventory Days | Days | 263 | 14 | 1,912.6% | |
Debtors Days | Days | 343 | 643 | 53.4% | |
Net fixed assets | Rs m | 10,617 | 20 | 53,164.2% | |
Share capital | Rs m | 166 | 54 | 308.9% | |
"Free" reserves | Rs m | 7,265 | 19 | 39,098.5% | |
Net worth | Rs m | 7,431 | 72 | 10,274.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 91 | 24,444.1% | |
Interest coverage | x | 409.1 | 17.9 | 2,290.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.4 | 38.3% | |
Return on assets | % | 10.3 | 0.9 | 1,106.8% | |
Return on equity | % | 30.9 | 1.1 | 2,870.7% | |
Return on capital | % | 42.4 | 1.7 | 2,444.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 64 | 2,304.1% | |
Fx outflow | Rs m | 1,605 | 0 | 802,700.0% | |
Net fx | Rs m | -140 | 63 | -221.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -9 | -25,513.5% | |
From Investments | Rs m | -215 | NA | 71,666.7% | |
From Financial Activity | Rs m | -985 | NA | - | |
Net Cashflow | Rs m | 1,160 | -10 | -12,149.7% |
Indian Promoters | % | 0.0 | 28.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.4 | 5,120.5% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 71.3 | 67.6% | |
Shareholders | 56,778 | 33,879 | 167.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | ZENITH HEALTH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.00% | 0.45% |
1-Month | -1.15% | 5.23% | 2.55% |
1-Year | 0.73% | 1.76% | 56.14% |
3-Year CAGR | -8.76% | -13.92% | 15.22% |
5-Year CAGR | 4.97% | 12.85% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the ZENITH HEALTH share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ZENITH HEALTH the stake stands at 28.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ZENITH HEALTH.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
ZENITH HEALTH paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ZENITH HEALTH.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.